<DOC>
	<DOCNO>NCT01021124</DOCNO>
	<brief_summary>The aim study estimate usefulness T cell-based assay ( i.e . Quantiferon-Gold In-Tube assay ) diagnosis latent tuberculosis infection ( LTBI ) bone marrow transplant recipient . For purpose , investigator enrol bone marrow transplant recipient observe developement tuberculosis transplantation .</brief_summary>
	<brief_title>Latent Tuberculosis Infection Bone Marrow Transplant Recipients</brief_title>
	<detailed_description>All adult bone marrow transplant recipient admit Asan Medical Center enrol . Quantiferon-Gold In-Tube assay perform . Isoniazid prophylaxis give patient clinical risk factor ( i.e . recent contact active pulmonary TB patient inadequate treatment history abnormal CXR ) . However , isoniazid prophylaxis give base positive TST positive Quantiferon-Gold In-Tube assay .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Latent Tuberculosis</mesh_term>
	<criteria>Age 16 Bone marrow transplant recipient Recent contact patient active pulmonary tuberculosis Suspected active tuberculosis</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>tuberculosis</keyword>
	<keyword>bone marrow transplant</keyword>
	<keyword>diagnosis</keyword>
</DOC>